InvestorsHub Logo
Post# of 251710
Next 10
Followers 69
Posts 2711
Boards Moderated 0
Alias Born 02/25/2010

Re: DewDiligence post# 183088

Saturday, 10/25/2014 5:56:08 PM

Saturday, October 25, 2014 5:56:08 PM

Post# of 251710
RGLS

The idea this is worth ~450M (17.33 - 6.77 x 43.34M OS) more today than 2 days ago seems absurd.

- 7-day data were only ~2.5 logs when you exclude the one rapid responder. Even at day 29, most had ~3 log reduction

- Running a trial in the US will be very challenging

- FDA has recently told Santaris they would need quite long follow up data ( 5 years )

- FDA unlikely to approve a drug based on RVR data and will still require 12 weeks. I don't see any reason for them to change their minds here especially with Harvoni and ABBV regimen coming.

http://files.shareholder.com/downloads/AMDA-14LKIJ/3566165809x0x787853/66089b1b-f1db-47f2-8972-355f0cbc8ae9/RG-101%20PoC%20Presentation%2010%2022%2014.pdf

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.